Immune Modulation 2011 (awaiting BANT CPD approval)
A must for all healthcare practitioners and students
Dates: 2011 - TBC
Times: 10am - 5pm
Venue: CNELM, 2 Edward Court, Wellington Road
Organisers: CNELM
For Prices and Registration details: coming soon!
Speakers include:
Liz Copeland MA Cantab - TBC
Ian Craig MSc - TBC
Dr. Alex Concorde - TBC
Michael Ash BSc - TBC
Dr. David Hefferon - TBC
Dr. Geoffrey Douglas - TBC
You will find out about:
Immunology is a relatively new field of healthcare. Research in this field is now prolific, fascinating, complex and frequently contradictory. The module will take a specific focus on a nutritional approach to the management of allergies, infections, inflammatory bowel disorders and auto-immune diseases. The module will also review the important role that the digestive tract plays in immunity and as an interface between the internal and external environment of the human body. The module will also explore toxicology and its potential impact on the immune system.
According to the National Office of Statistics, Great Britain ranked
second highest for the prevalence of symptoms of eczema, third highest
for asthma symptoms and thirteenth for rhinoconjunctivitis, compared to
56 other countries.
Autoimmune diseases are complex and varied. The incidence of Type 1 diabetes,
for example, has been reported to have doubled every twenty years since
1945 and globally it is reported that 20 million people have Type 1 diabetes.
It is reported that 1:100 people suffer with Coeliac disease in the UK,
a disease previously associated with babies and failure to thrive. Now
many adults between 35 and 45 are diagnosed with the disease. It is more
commonly associated with those with Type 1 diabetes, autoimmune thyroid
disease, MS and ulcerative colitis.
Learning outcomes: the activity should enable the participant to:
1. Critically evaluate complex, incomplete and/or contradictory data to justify the fundamental importance of digestive health in immunocompromised individuals.
2. Offer resolution to informational conflicts, using own ideas, when data concerning digestive health and immunocompromised individuals is contradictory.
3. Justify treatment decisions for an immunocompromised individual where gut pathology and toxicology play a part.
4. Draw on a range of sources of evidence to cogently present a clinical approach taking social, cultural and ethical factors into account for an immunocompromised individual with gut pathology and toxicology in writing and verbally.
5. Justify the use of clinical investigations to support treatment decisions for an immunocompromised individual with gut pathology and toxicity issues to address in writing and verbally.
6. Influence and be influenced by the learning of peers towards improved treatment decisions for immunocompromised individuals with gut pathology and toxicity issues to address.
7. Honour the beliefs, attitudes, strengths and limitations of peers and maintain ‘State’ if own ideas are challenged when discussing the immunocompromised individual with gut pathology and toxicity.
